Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management.
Mónica HigueraElena Vargas-AccarinoMaría TorrensJosep GregoriMaría Teresa SalcedoJoan Martínez-CampreciósGloria TorresMaría Bermúdez-RamosItxarone BilbaoMercedes Guerrero-MurilloXavier Serres-CréixamsXavier MerinoFrancisco Rodriguez-FríasJosep QuerBeatriz MínguezPublished in: Cancers (2022)
In summary, cfDNA and detection of prevalent HCC mutations could have prognostic implications in early-stage HCC patients.